Federated Hermes’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $300M | Buy |
1,999,178
+111,594
| +6% | +$12.1M | 0.43% | 57 |
|
|
2026
Q1 | $174M | Sell |
1,887,584
-143,978
| -7% | -$14.5M | 0.28% | 81 |
|
|
2025
Q4 | $208M | Buy |
2,031,562
+255,193
| +14% | +$22.8M | 0.35% | 73 |
|
|
2025
Q3 | $111M | Buy |
1,776,369
+310,931
| +21% | +$16.9M | 0.2% | 132 |
|
|
2025
Q2 | $76.3M | Buy |
1,465,438
+615,429
| +72% | +$27.5M | 0.14% | 176 |
|
|
2025
Q1 | $36.2M | Sell |
850,009
-112,713
| -12% | -$4.86M | 0.08% | 294 |
|
|
2024
Q4 | $29.4M | Buy |
962,722
+99,072
| +11% | +$2.79M | 0.06% | 325 |
|
|
2024
Q3 | $19.8M | Buy |
863,650
+1,550
| +0.2% | +$43.9K | 0.04% | 429 |
|
|
2024
Q2 | $24.9M | Sell |
862,100
-44,800
| -5% | -$1.04M | 0.06% | 355 |
|
|
2024
Q1 | $18.7M | Sell |
906,900
-300
| -0% | -$6.43K | 0.04% | 427 |
|
|
2023
Q4 | $24.5M | Sell |
907,200
-202,300
| -18% | -$5.31M | 0.06% | 343 |
|
|
2023
Q3 | $32.9M | Buy |
1,109,500
+200,500
| +22% | +$7.05M | 0.09% | 264 |
|
|
2023
Q2 | $32.5M | Buy |
909,000
+300,000
| +49% | +$8.62M | 0.08% | 284 |
|
|
2023
Q1 | $14.3M | Buy |
609,000
+113,918
| +23% | +$3.25M | 0.04% | 464 |
|
|
2022
Q4 | $13.5M | Buy |
495,082
+444,482
| +878% | +$20.3M | 0.04% | 470 |
|
|
2022
Q3 | $2.72M | Sell |
50,600
-10
| -0% | -$513 | 0.01% | 824 |
|
|
2022
Q2 | $2.04M | Sell |
50,610
-36,690
| -42% | -$1.82M | 0.01% | 922 |
|
|
2022
Q1 | $5.78M | Sell |
87,300
-12,700
| -13% | -$869K | 0.01% | 742 |
|
|
2021
Q4 | $10M | Hold |
100,000
| – | – | 0.02% | 644 |
|
|
2021
Q3 | $12.5M | Hold |
100,000
| – | – | 0.02% | 591 |
|
|
2021
Q2 | $12.4M | Hold |
100,000
| – | – | 0.02% | 593 |
|
|
2021
Q1 | $15.3M | Hold |
100,000
| – | – | 0.03% | 560 |
|
|
2020
Q4 | $12.9M | Hold |
100,000
| – | – | 0.03% | 573 |
|
|
2020
Q3 | $11.2M | Hold |
100,000
| – | – | 0.03% | 546 |
|
|
2020
Q2 | $8.11M | Buy |
+100,000
| New | +$8.06M | 0.02% | 599 |
|
|
2019
Q4 | – | Sell |
-62,099
| Closed | -$3.96M | – | 2247 |
|
|
2019
Q3 | $3.96M | Sell |
62,099
-56,401
| -48% | -$4.97M | 0.01% | 830 |
|
|
2019
Q2 | $10.2M | Buy |
118,500
+25,000
| +27% | +$1.91M | 0.02% | 580 |
|
|
2019
Q1 | $7.17M | Sell |
93,500
-31,500
| -25% | -$1.75M | 0.02% | 677 |
|
|
2018
Q4 | $4.7M | Buy |
+125,000
| New | +$4.61M | 0.01% | 749 |
|
Other funds holding GH
DTC
Federated Hermes's GH Position: Q2 2026 in Review
Federated Hermes increased its Guardant Health (GH) stake by 5.9% in Q2 2026, buying an estimated $12.1M and bringing the position to 1,999,178 shares worth $300M. The position accounts for 0.43% of the portfolio, ranked #57.
Federated Hermes first reported a position in GH in Q4 2018 and has held it in 29 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Federated Hermes held 1,999,178 shares of Guardant Health worth $300M as of Q2 2026.
- Federated Hermes bought 111,594 Guardant Health shares in Q2 2026, an estimated $12.1M.
- Guardant Health made up 0.43% of Federated Hermes's portfolio in Q2 2026, its #57 holding.
- Federated Hermes first reported a position in Guardant Health in Q4 2018 and has held it in 29 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.